FactEvidence 2
ownsRoche
Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.
PR Newswire news releases · 2026-10-07 13:00
View evidence
- CompanyPR Newswire news releases2026-10-07 13:00
Roche is the majority shareholder in Chugai Pharmaceutical, a major innovator in the Japanese therapeutic antibody market.
View source - CompanyPR Newswire news releases2026-10-07 13:00
Roche is the majority shareholder in Chugai Pharmaceutical
View source